Literature DB >> 2833744

cDNA cloning of human DNA topoisomerase I: catalytic activity of a 67.7-kDa carboxyl-terminal fragment.

P D'Arpa1, P S Machlin, H Ratrie, N F Rothfield, D W Cleveland, W C Earnshaw.   

Abstract

cDNA clones encoding human topoisomerase I were isolated from an expression vector library (lambda gt11) screened with autoimmune anti-topoisomerase I serum. One of these clones has been expressed as a fusion protein comprised of a 32-kDa fragment of the bacterial TrpE protein linked to 67.7 kDa of protein encoded by the cDNA. Three lines of evidence indicate that the cloned cDNA encodes topoisomerase I. (i) Proteolysis maps of the fusion protein and human nuclear topoisomerase I are essentially identical. (ii) The fusion protein relaxes supercoiled DNA, an activity that can be immunoprecipitated by anti-topoisomerase I serum. (iii) Sequence analysis has revealed that the longest cDNA clone (3645 base pairs) encodes a protein of 765 amino acids that shares 42% identity with Saccharomyces cerevisiae topoisomerase I. The sequence data also show that the catalytically active 67.7-kDa fragment is comprised of the carboxyl terminus.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2833744      PMCID: PMC280033          DOI: 10.1073/pnas.85.8.2543

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

Review 1.  Proteins that affect DNA conformation.

Authors:  J J Champoux
Journal:  Annu Rev Biochem       Date:  1978       Impact factor: 23.643

Review 2.  DNA topoisomerases.

Authors:  J C Wang
Journal:  Annu Rev Biochem       Date:  1985       Impact factor: 23.643

Review 3.  Molecular biology and genetics of tubulin.

Authors:  D W Cleveland; K F Sullivan
Journal:  Annu Rev Biochem       Date:  1985       Impact factor: 23.643

Review 4.  DNA topoisomerases.

Authors:  M Gellert
Journal:  Annu Rev Biochem       Date:  1981       Impact factor: 23.643

5.  Eukaryotic DNA topoisomerases: two forms of type I DNA topoisomerases from HeLa cell nuclei.

Authors:  L F Liu; K G Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1981-06       Impact factor: 11.205

6.  Aberrant neurofilament phosphorylation in Alzheimer disease.

Authors:  N H Sternberger; L A Sternberger; J Ulrich
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

7.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

8.  Cloning of yeast TOP1, the gene encoding DNA topoisomerase I, and construction of mutants defective in both DNA topoisomerase I and DNA topoisomerase II.

Authors:  T Goto; J C Wang
Journal:  Proc Natl Acad Sci U S A       Date:  1985-11       Impact factor: 11.205

9.  Replication of pBR322 DNA in vitro with purified proteins. Requirement for topoisomerase I in the maintenance of template specificity.

Authors:  J S Minden; K J Marians
Journal:  J Biol Chem       Date:  1985-08-05       Impact factor: 5.157

10.  Mitotic spindle pulls but fails to separate chromosomes in type II DNA topoisomerase mutants: uncoordinated mitosis.

Authors:  T Uemura; M Tanagida
Journal:  EMBO J       Date:  1986-05       Impact factor: 11.598

View more
  69 in total

1.  Potential protein partners for the N-terminal domain of human topoisomerase I revealed by phage display.

Authors:  Agata M Trzcińska; Agnieszka Girstun; Agnieszka Piekiełko; Barbara Kowalska-Loth; Krzysztof Staroń
Journal:  Mol Biol Rep       Date:  2002-12       Impact factor: 2.316

Review 2.  B-cell epitopes of scleroderma-specific autoantigens.

Authors:  R Verheijen
Journal:  Mol Biol Rep       Date:  1992-06       Impact factor: 2.316

3.  Purification and characterization of a proteolytic active fragment of DNA topoisomerase I from the brine shrimp Artemia franciscana (Crustacea Anostraca).

Authors:  G Badaracco; N Landsberger; R Benfante
Journal:  Biochem J       Date:  1992-02-15       Impact factor: 3.857

Review 4.  Antinuclear antibody determination methods.

Authors:  D G Williams; P J Charles; M Field; S M Chua; R N Maini
Journal:  Clin Rheumatol       Date:  1990-03       Impact factor: 2.980

5.  A TaqI RFLP at the human TOP1 pseudogene locus on chromosome 22q11.2-13.1 (TOP1P2).

Authors:  A D Auerbach; R G Allen; W R Mann
Journal:  Nucleic Acids Res       Date:  1991-07-25       Impact factor: 16.971

6.  Autonomous parvovirus DNA replication requires topoisomerase I and its activity is increased during infection.

Authors:  M L Gu; S L Rhode
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

7.  Mapping the active-site tyrosine of vaccinia virus DNA topoisomerase I.

Authors:  S Shuman; E M Kane; S G Morham
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

8.  Human topoisomerase 1 messenger RNA is not destabilized by the herpes simplex virus type 2 virion-associated shut-off function.

Authors:  K F Bastow; B S Zhou; Y C Cheng
Journal:  Virus Genes       Date:  1989-08       Impact factor: 2.332

9.  T cell proliferative response induced by DNA topoisomerase I in patients with systemic sclerosis and healthy donors.

Authors:  M Kuwana; T A Medsger; T M Wright
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

10.  Molecular cloning of a cDNA of a camptothecin-resistant human DNA topoisomerase I and identification of mutation sites.

Authors:  H Tamura; C Kohchi; R Yamada; T Ikeda; O Koiwai; E Patterson; J D Keene; K Okada; E Kjeldsen; K Nishikawa
Journal:  Nucleic Acids Res       Date:  1991-01-11       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.